Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sun Trust bank has owned these 10M shares for a while, I think at least a year or so. we just never saw any announcement of how they were acquired. Obviously not bought in the open market because have not even traded that many shares, plus we would be higher in price with that many shares purchased. My guess they got some cash or they did some accounting work or something like that We don't know what price they were given at, if there are restrictions on selling or anything. I heard after the AMBS deal the cone of silence was lifted. Well no news EVER!!!!!!!
It has been 8 years now. So I would think thousands of burn victims are being treated with current technology and doing fine. If this was so great it would of been funded by now. We can only hope (which is never a good investment strategy) that things are at least progressing, but oh so slowly...
Discala was/is a crook and has been indicted. Broadsmore group does not own any stock. These two have been out of the picture for awhile. We are in waiting mode for financing. Has it taken awhile heck yes, but can only lose 7 cents. FB shares dropped more than that!!!!
Oh no SPY fell 6 points in a few minutes, Call CNBC, get Buffet out there, have a FED guy say no bubbles anywhere, that's right Kaskari did that. Oil no problem, 10yr rate no problem inflation oh no where to be seen. Its all good. Have all the MM buy same 3 stocks we cant be down its against the law buy AMZN at stupid level add to AAPL Trillion dollar company really makes a new phone uses same batteries but don't say that. FB We need more time wasting technology. Buy Mortimer Oh good its green Tell Buffet to go home and sit in tub....
This market wanted to tank but FEDs didn't want it to so they get Buffet to say I bought AAPL 3 months ago...Who cares and everyone buys What a joke. Feds told firms to buy and ignore all the news we will release today apparently
1. Trump wanting 200M vs 100M in tariffs is ok now
2. Dudley saying Oh inflation over 2% that's ok
3. Another Fed guy saying yeah 3-4 hikes looks good
4. Flattening yield curve sucks for banks but there up
Want to short it but not sure how far going to push it. Only 5 red bars on the 10 minute chart for the day, unheard of, and not once fell below the SMA (9) once it hit it. This is just a massive short covering and a screw job.
Well just like yesterday close near 262.80 I think they need to get to 264.15 just for fun. re-short going to break below 258 one of these days.
Well we got the range at least 21.75 so machines are happy. But I would like to see a 262.80 close Needs some volume there.
Average range even on slow days is 19-22 points, So we hit 266 or 263. Killing OTM put vol, so they are loading up to first or collecting premium.
They have raised earnings levels up quite a bit so I think the biggest danger is a miss, besides those high levels are priced in. I'm more interested in everyones forward guidance with the tariffs. May be reluctant to give clear guidance or widen guidance. Plus weaker dollar keeping money away. AMZN, BA, CAT, FB, GOOG. Leaders are faltering. Rotation will knock us down. Better buying ahead.
Someone artificially keeping this market up. Buy on dips over and over but we go nowhere. Staying short on all rallies and adding until hit 248-252. Thats the spot, this is just goofy noise. Yesterday everyones Bot buys at same time, so colluded, runs to 261.13, then drops 50 points overnight. Sell any rallies until the big drop. Thats my story and I'm trading to it...
10K is out
STILL LOOKING FOR MONEY TO MOVE FORWARD, BUT PROCEEDING ON THE WORK TO GET TRIALS STARTED.
Overview of key events of the year ended September 30, 2017
During 2016-17, the Company had been positioning its product, NovaDerm, to enter clinical trials to gain FDA product approval. Having secured Orphan Designation for NovaDerm, we completed the necessary independent research and executed several key supply and manufacturing contracts to pave the way toward a pre-IND meeting with the FDA. The IND is an investigational new drug application filed in order to receive permission from the FDA to enter into the clinical trial process. Our pre-IND meeting with the Agency was very successful and clearly defined some additional requirements we needed to begin the clinical trials and the agreed upon protocols we needed to perform the trials. It was further agreed that the trials would initially cover 3 patients and then would be extended to 7 additional patients. If approved, NovaDerm® will be the first and only autologous, cultured skin substitute product allowed for medical use on burns requiring grafting.
We estimated that the completion of the IND and the clinical trials would take approximately 12-18 months and cost in the range of $3.5 -$4.5 million. In addition to the completion of the IND, the only other significant gating item to entering the clinical trials is funding.
On December 26, 2016, Dr. Joseph Rubinfeld, one of the original Board Members, unexpectantly passed away. On August 7, 2017, Dr. Craig Eagle, also an original Board Member resigned to pursue other interests. The Company is grateful to these two gentlemen for their support and contributions during the past seven years.
These two board positions remain open anticipating requests of Board representation from potential investors.
The following is a review of the major milestones achieved during the year:
1. Our contract laboratory completed the laboratory portion of their analytical research services and we received their final report. This was a lengthy process in which we identified certain potential product improvements that we continue to evaluate internally. The final research report was a crucial part of our FDA submissions for an Orphan Designation and Pre-IND (Investigational New Drug).
2. We filed our annual report for our Orphan Designation, as a biologic, with the Office of Orphan Products Development of the FDA for the treatment of burns requiring skin grafting with NovaDerm®. The Orphan Designation granted is for “treatment of patients with deep-partial or full-thickness thermal burns requiring grafting”. The FDA's Orphan designation is granted to promote the development of unmet clinical needs with new therapies for rare diseases and disorders. Orphan Product terminology is applied to Orphan designated products proven safe and effective, and the approved Orphan Product entitles the product, up to seven years of US market exclusivity. In addition, there are other financial benefits along with the FDA’s support during the approval process.
3. We are following through on the results of our FDA pre-IND meeting. During the Pre-IND meeting The Agency addressed our questions and provided guidance on our planned NovaDerm® development pathway going forward. It was agreed that Bovine TYPE 1 hide collagen scaffolds from Pure Med Farma, LLC (a related company) would satisfy American Society of Testing and Materials testing to fulfill current ASTM Type I requirements. We are working closely with Pure Med Farma to ensure this testing complies.
4. We have continued to work on finalizing the IND as funds allow. An IND application is the document filed with the FDA to request permission to proceed with clinical trials. This application includes the candidate product's research, chemistry, manufacturing controls and processes, pre-clinical safety, clinical trial protocols, and more.
3
Table of Contents
Our Business Moving Forward In 2018
The company’s major objective for 2018 remains to secure the required funding to finalize some additional requirements of the IND application, and begin the clinical trials. It is estimated that the cost to finalize the IND will be approximately 1.5 million dollars, and the cost to complete Phase 1 of the clinical trial will be approximately 2 million dollars. As previously reported, our goal in obtaining this funding has been to minimize shareholders' dilution as much as possible. Consequently, we are primarily pursuing financing through the issuance of a debt instrument and international licensing agreements.
We have worked with a number of potential investors and continue to pursue the necessary funding based on our stated objectives. It has taken longer to raise the funds than originally estimated; however, we remain confident that our goal is achievable. In the interim, the officers and related parties intend to continue to fund the Company’s essential operating costs.
We have begun the preliminary planning for the clinical trials to the extent we are able, considering funding constraints. As previously reported, we have chosen a CRO to assist in our IND submission and conducting the trials. Clinical site selection and patient recruitment should be somewhat simpler than other clinical trials, as we are limited in site selection to the 150 burn centers qualified to treat catastrophic burns. In addition, the surgical protocol will be similar to the grafting procedures currently in use at those facilities. NovaDerm® should thus require minimal physician training.
The initial trials are planned to begin with a total of ten subjects with an Initial Data Safety Monitoring Board (DSMB) review of safety on the first three subjects once they have reached 6 months follow-up. We do not intend to interrupt our trial waiting for the DSMB report.
Our management is considering various possibilities and approaches to obtaining clinical trial materials and manufacturing. While no final decision has been made, management’s approach is to set up the trials so as to allow for a seamless transition into commercial production upon approval.
There are so many moving parts.
- McCoy consulting firm
- PureMed
- Life Sciences
- RGIN
Now everyone in RGIN is on PM's board. Nelson runs PM. They have the only FDA APPROVED facility in US. They are the main distributor on LS product. So if falling out with McCoy that's not end of the world at all. They have own producing facility in Alabama. Besides there are many more farms moving to collagen as way more profitable, so LS not only game in town.
Its about getting financing and into trials. There are many more people involved then just RGIN employees. Its just that stock will get the benefit
What they were looking to accomplish in 2017:
Obviously Late: But this next report is VERY IMPORTANT
• Secure interim financing to finalize product development needed to support the IND;
• Complete a second round of financing in order to conduct 10 patient clinical trials with NovaDerm® and finalize required manufacturing engineering runs and validations;
• Work with Pure Med Farma to finalize Collagen Scaffold Testing Specifications for NovaDerm®;
• Finalize contracts with the CRO and select the NovaDerm® clinical trial material manufacturer;
• Retain a Principal lead investigator, medical advisor, surgical trainer and dermopathologist;
• Select and execute contracts with two clinical study sites; and
• Perform a successful graft of NovaDerm onto a clinical trial subject.
No one really knows where this will go. I see it in stages which is way better than a huge pop, everyone sells and shorts then goes back to no trading volume. So for news:
1. Lets see what funding is: Do they dilute stock when receive funding, that's a biggie, or is it a big loan, or is it giving some of company away. So watch that.
2. How long will FDA approval take: Is it a 1 yr process or 2 year process. If its long then guys may wait to buy it, if shorter than buyers will hold.
Institutions cant buy until above $5, so I hope don't split stock, so they can buy it, that's bad because will probably hammer it and short it.
Clarity on the consulting company
How will news be discussed during trials. If we wait with no news again, then at end they say approved or not, that is not good.
If approved will probably be bought out just like many of the other companies I have stated in this space.
These guys have been trying to get this to market since bought the technology in 2010, as I was an initial investor at .62. Averaged down a lot and still hold, it just seemed to take forever, but if done right, that's a good thing.
Also, there are many articles on the consulting company. life Sciences and other stories on the NZ collagen market. The entire market for all this is roughly $118B. So plenty to share. Great article last May how the entire region is looking to do this because way more profitable than farming. Type in McCoy or Life Sciences, or NZ closed herd, you will see they have been busy all year. Probably buy dips until news, cant really lose much at this cheap price.
Lots of talk but no one seems to really know what is going on. I guess things are happening. McCoy has his Consulting firm and they are linked up with Life Sciences in NZ. They are legit and they offer many more things besides the collagen. That's where John Weber is, so he is still involved. Looks like hooked up with Meta Alliance, They are a firm that gets involved in financing as well as other things. So that's the group putting or trying to get funding together.
I guess when he has something definite we will here something but the right people seemed to be involved from various industries. Seems strange that he was not making any announcements all year about the McCoy consulting firm and other discussions. Maybe wants to get it all together no one knows.
As far as a stock pop, I see someone saying $3-$6. That has about a .001% chance. There are 154M shares outstanding, so its not going to be a 500M -$1B company on a little financing. I would like to see $50 - $100M market cap so maybe .30 to .60 cents at first then see if they get going and move forward.
Good luck all....I just wouldn't be short, can make .13 cents but lose much more.
Don't let those sneaky market makers steal shares from you. Who is dumping at .095 cents? Really No news out and just a vacumn. Guys panic and market makers get cheap shares. Stay long, they are accumulating shares, then will run it up in shorts or guys who got out's face.
If there is a big bid in level 2, they will sell to get someone to sell along with them so they can be filled at their price. Look what happened once .095 traded. Next trade .1055 then up to .1075, then 11, 11.5 13.5, .14 then .15 (last few on low volume, but low was 50% LESS).
Here are other companies in 10K, either bought out or much bigger market caps, so there is definitely a big interest in this market. Raising debt for $2-4M should not be hard.
Mkt Cap
Amarantus Biosciences, Inc. 1.7M
Smith & Nephew Wound Management 14.5B
Genzyme Biosurgery bought Out
Integra Life Sciences Corporation 3.2B
LifeCell Corporation/Kinetic Concepts KCI bought Life for 1.7B in 2009, sold in 2016 to Alergan at 2.6B
Organogenesis Inc private but have 2 products 240 employees, new product announced Oct 2016
Intercytex liquidated and became private in 2010
Genzyme bought out
Advanced Biohealing/ Shire huge 50B, busted for kickbacks on their dermaplast
Cy Ttera/ NovoCell/ViaCyte all merged partners with Perkins Elmer, mostly diabetes
Biomimetic Therapeutics Inc. bought by wright medical 2.5B
RTI Biologics 200M
With RGIN at 20M Market Cap, still cheap.
Did Randy sell any AMBS when it popped up to $1,40 during that rally. That $30M or so would of came in handy. Now at $.06. Even when AMBS was rallying and we hold a good amount of shares RGIN, didn't rise.
Said on Feb 16th that there would be more news articles and info coming, I expected at least 1 announcement in the last 5 weeks.
RGIN owns $3M in AMBS stock. If still own it, that stock is up from .35 to $1.21. Would seem RGIN should pop up a bit. Maybe sold all of it. Any thoughts here? Or is Randy just going to issue stock forever, dilute current holders, then do reverse split so guys can short it. That's what happened to AMBS, it let guys short it since was above $5.
D0 we know if Randy has been selling his stake in AMBS? I would assume that if he did, then he would disclose it. The stock went to 35c, now bounced up to 65c in last 3 days. Would hate to see he dumped all near lows now out. Any reason why not giving updates to us? Now have 156M shares outstanding, last time I checked was 135M. So we are getting so diluted here. Doubled shares outstanding almost in a few years. So company getting money, and no announcements, or anything. Seems like he issues shares to pay himself, phone bills etc.. We have no control, this can go on forever and he can issue until 1B shares outstanding. What or who will stop him?
I think all when and good, Yes Sandy news is worthless, not sure why spends time on this but where is Randy? Last 5 messages to him , no response he always responded. Lonza out of picture for a year, not one thing said. So Everest, why are you telling us about this new way of Novaderm? The company should. Where are you getting your information from to make these statements?
Thanks it's Zero or a homerun......
Nothing has changed, I did see a pop today up to .0375, but settled lower, 2 months ago sent email to Randy, no response, last month email, and no response Over the last 5 years he responded to every one. So no one knows but since it is not lower, something probably going on, but he is so scared of any lawsuit I guess he says nothing. So been holding here. Maybe one day it will go up and stay up. I think if it was bankrupt the market makers would know and we would be at 1/2 cent. So anyway Long shot. But just holds that 50 day MA, Another Friday Lets have a good close!!!!!
Well AMBS dropping not helping, goes from .10 to .05 cents, thats a almost $2M hit for RGIN, that sucks, too bad not sold to a company thats honest and decent. Reading their message board is basically saying CEO a criminal and diluting stock. We need Randy to give guidance and news. Said was going to do that after Lonza crap over; well it is. He has til May 5th before can sell, wonder if he'll dump at any price? Wonder if he'll tells us when he sells. News Randy, no one stopping you now. What does company do all day?
I agree, but you asked why not higher. We need to get investors excited and emotionally involved, but the company has started in 2010 and the only thing that happened is they got in a lawsuit, and almost tripled the number of shares outstanding (was 86M, now near 200M) If any, I mean any decent news comes out like starting FDA approval, or Orphan status, or started making skin in their new facility, it's a .15 - .25c stock. I believe in product, but need to convince new shareholders to come in and buy. Like I said before, have 6M in cash/stock, and worth 6M after taking into consideration all warrants and options.
I agree. Sandy Frost is old news and garbage because not doing the process that way anymore so she is irrelevant. As far as the stock, it seems to be priced for the current value but nothing more. They have apprx. 150M shares outstanding with options and warrant for another 40M, and they just gave an "officer" 10M shares, sure would like more info on that , whoever it was received ITM (in-the-money) options, struck at .02c?? That is a big gift.
Anyway
200M shares at .03 = $6M
Cash 3.5M + AMBS stock (37.5M * .08c) =3.5M
So it is priced right. They even eliminated $2M in debt
What is not priced in is anyone thinking it is going to work. There is no "premium" here, so your buying intrinsic value.
They can't sell stock of AMBS until May, so when they do, if no news and nothing changes. RGIN will probably stay flat or drop as well. He needs to get info out to investors and get moving.
I would think at this level a "premium" is warranted. Pushing up to .075c to the 200 day MA seems possible.
Looks like Joseph Rubenfeld was at RGIN, did nothing, got stock, then leaves goes to AMBS, gets 6.9M shares ($500K) Seems a little strange how a well known guy is bouncing around with penny stocks. He will probably broker the RGIN to another company soon. I'm guessing all these guys are buddies and they just do this stuff to get paid. I'm sure we don't know whole story of what the heck is going on.
Looks like deal closes in 9 days. What price did they get AMBS at .08 cents? Is that done and we own 37.5M shares? Did not see that anywhere. Randy said out of the hush hush period he was under with Lonza, Lets see if we can get a few announcements a month. Not much in last few months at all, would like to see that finally change.
What the heck just happened? Dr Rubenfeld goes to the other company on their board. So abandoned RGIN. RGIN gets 3.5M cash plus $3M in stock, and RGIN is only valued at 1.2M? I can not tell if good or bad. RGIN will use proceeds to continue doing what? Amarantus will work with LONZA and others for the ESS. Is RGIN starting from scratch or did Randy just get 6.5M to play with for retirement. Has no one to do the work. Who is going to watch how he spends the money?? Seems like you sell RGIN and buy Amarantus at even or better.
It is still in the hands of the courts, nothing has change for 6 months but Sandy crap and other posts were added. SO no change at all, still a binary trade. If in RGIN's favor then we pop up and get things through trials, if not then ZERO!!!
So I give it lets say 10% it is in RGIN favor (stock pops to 25 cents if in their favor ) if NOT 90% goes to 0.
so .1 * .25 = .025
.9 * 0 = 0
So I think stock should be at .025 cents right now and will adjust % as news, if ever comes out. NOW they need to stop giving away cheap shares. Good luck
Company still around. 2 weeks ago was 129M shares last week 131M shares just looked today 135M shares. So Randy just still diluting at .0025!!! Wow, giving a buddy 4M shares for a $1K? Why doesn't the board or Randy put money in? I guess they don't believe anymore. They have about another 40M or so to issue, then that will be it, unless they decide to increase share to 1B so he can still collect a paycheck.
If there was a DOD issue and an investigation they (RGIN) would have to disclose. But nothing has been said. Nothing has changed, it's lawsuit win or lights out. Bought another 1M shares, so average is about 1 cent.
Old news Everyone knew about the Sandy Frost stuff when it happened. Not one thing in that has anything to do with once RGIN bought patent in 2010. it is Lonza and RGIN now. Look at date on all articles it's 2006-2007. Why would anyone recycle this crap. But looks like it got people scared. It's a long shot. Randy gives no news, maybe he is lawyering up. I'm sure it is still in courts, but can they hold on until a judgement.
Below a penny!!!!!!!!!!!!!!! No buyers. Write off for this year. Even if your not a believer and want out too bad. Can't sell much. Looks like current shareholders wiped out. If he raises money in stock needs about 2B shares at .0025 or .05 cents, (5-10M) so we get about 1% of company. Thanks Randy.
GOOD BYE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
I couldn't even tell you who works there anymore. I would guess a typical day is Randy tries to raise money, that's about 99% of his time, and he gets a call once a week or so from a lawyer, updating him on the Lonza lawsuit. So it is a race against time. They will continue to issue stock. (issued another 10M shares last qtr) Almost 10% increase in stock!!!!!!!!!!! We as current shareholders can't make any money here.. The new money gets stock in warrants, preferred etc, at basically free, so selling here at .01 is still good for them. Hard to buy here at .013 or so when a guy is getting it for much less. So have 130M outstanding, 200M authorized need about 15M for convertible. So once issue 55M more shares will probably just increase share count and continue to do that until can't or lawsuit finalized. If they lose, then all initial investors will file suit, since were told they are buying the rights, APPARANTLY they were not. Would like to see initial contract. Having said that, product works, but looks like Randy running out of time. I sold 1/2 position at .0375, felt that was low, but made money. Now long 1m shares at average of .025 cents, Still don't feel like averaging down.
No one is questioning if it will work, because it does. The issue is will RGIN be the one to take to market and get FDA approval. Have no cash and need to raise money, (hard to do when a penny stock) legal issues, etc.. Who are they competing against. What about the other 12 firms that LONZA licensed product too? Or what about MERCK or Pfizer or anyone else. With no news it is frustrating, besides the 10Q of course. Was also frustrating to see them reduce option price from 68 cents to 3.5 cents for insiders, that was a no confidence vote in my book.
Look at stock weekly now, Looks like failed again for the 5th time at the weekly 50 DMA. Never been able to hold above since Jan 2012. Also below the Daily 50 DMA and the Daily 200 DMA. Looks like the computers just trade .015 - .03 for now. Ready for the breakout!!!!!!
Good questions get asked but I have never seen a good answer. They are working on stuff, but news from company is non-existent. Huge sellers at .03. There are 50,000 offered at .0294 and 2.5M offered at .03. So if you want to get a big position, here is your chance. Staying above daily 50 day MA, but has failed at weekly MA 5 times over last 2 years. It is at .0292. So if blow through the big sellers at .03, can move. If gave more news probably have more interest in the stock..
Now that's volume!!!! 100k is average, so selloff was nothing......
Here is the link to the motion back in Feb
http://cdn.lettersblogatory.com/wp-content/uploads/2014/03/gov.uscourts.gand_.199728.21.0.pdf
Seems like LONZA thought the 93 page report was a shotgun approach by RGIN. Now they filed a 396 page one? Seems strange. Judge wanted specific things, who are you suing Walkersville or Switzerland Lonza etc... They filed in time I guess, but they never release news. So no idea whats going on. It's a binary trade, news will be got Orphan Status or settled with Lonza (positive) or we are shutting doors. At .0187 NO BUYERS!!!!!!
Everest72
Where is this 329 page one at? We all saw the 93 page one, it is on website, but no other news on there after Feb 19th. How could we of seen this? And where did you see it?
Thx
Lonza is a pain in the A$$. But I don't think Lonza lawsuit means as much anymore. They are out of picture.
If RGIN wins suit they get money. If lose no money but it doesn't stop them because they are looking to get "Orphan Drug " status in a different way. Now I am not sure who ones the Orphan Status that was handed out 2 yrs ago. I guess that is part of suit, but its good RGIN is moving forward. So RGIN is moving on with a different way of skin production, not sure how long will take, but this way excludes Lonza. Questions I have are?
1. Are the other 12 companies or so that Lonza took money from suing.
2. Does this lawsuit zap all of Lonza's resources and time, and not moving forward?
3. Any talking going on between these two or just Lonza continually asking for stuff.
This seems so cut and dry. I put money in at beginning and was told buying product. Has anyone seen the original contract? I am going to ask for it since was initial investor. Stay long
State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 120,709,400 as of February 14, 2014. Handing shares out like candy on Halloween.
If they need to raise 8-10M. That's going to be a lot of shares if they do it this way. Just doesn't state if the shares getting distributed now need to be held for a certain amount of time or they can be sold immediately.